23 May 2013
Keywords: novartis, emerging, white, knight, aventis, swiss, drug
Article | 09 February 2004
Swiss drug major Novartis may be eyeing up a counter bid to Sanofi-Synthelabo's hostile offer for Franco-German firm Aventis
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 February 2004
22 May 2013
© 2013 thepharmaletter.com